MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells

Xiaoyuan He1, Aimin Yang1, Daniel G McDonald2

  • 1Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.

Oncotarget
|October 21, 2017
PubMed

Insights

Ionizing radiation (IR) upregulates microRNA-34a (miR-34a) in non-small cell lung cancer (NSCLC) cells, promoting senescence and cell death. Targeting miR-34a may enhance lung cancer radiotherapy effectiveness.

Area of Science:

  • Molecular Biology
  • Oncology
  • Radiotherapy Research

Background:

  • MicroRNAs (miRNAs) regulate gene expression and are involved in cancer development and treatment response.
  • The specific role of miR-34a in ionizing radiation (IR)-induced senescence in human non-small cell lung cancer (NSCLC) is not well understood.

Purpose of the Study:

  • To investigate the role of miR-34a in IR-induced premature senescence in NSCLC cells.
  • To explore the potential of miR-34a as a therapeutic target for improving lung cancer radiotherapy.

Main Methods:

  • Transfection with synthetic miR-34a mimics or inhibitors to modulate miR-34a expression.
  • Assessment of IR-induced senescence.
  • Clonogenic assays to evaluate cell killing.
  • RNA interference (RNAi) to knockdown c-Myc (Myc) expression.

Main Results:

  • IR-induced premature senescence in NSCLC cells correlates with increased miR-34a expression.
  • Overexpression of miR-34a enhances IR-induced senescence and cell killing.
  • Inhibition of miR-34a attenuates IR-induced senescence.
  • miR-34a promotes senescence by down-regulating c-Myc expression.
  • Knockdown of c-Myc mimics the senescence-promoting effects of miR-34a.

Conclusions:

  • miR-34a plays a significant role in modulating IR-induced senescence in human NSCLC cells.
  • Pharmacological targeting of miR-34a could be a novel strategy to enhance the efficacy of lung cancer radiotherapy.